Organon is a renowned global pharmaceutical company with a strong commitment to human health care. The company develops and produces innovative prescription medicines for gynaecology, psychiatry, cardiovascular disease, immunology and anaesthesiology. Organon is the human health care business unit of Akzo Nobel. Its products are sold in over 100 countries. Organon is a global research-based, market-driven pharmaceutical company. Organon discovers, develops, manufactures and markets a wide range of high-quality, original prescription medicines, including products in the fields of gynaecology, mental health, immunology, thrombosis, and anaesthesia. Organon invests more than 18% of annual sales turnover in research – one of the largest proportional investments of any pharmaceutical company, and a total of 2,300 employees work in R&D—about 18 percent of the workforce.

Our objective
Organon’s objective is to be a reliable partner for health care professionals worldwide by providing products and services for improving human health and quality of life.

Our commitment
Organon takes an active role in the community, and is responsible not only to shareholders and employees but also to the millions of people who use Organon products. Organon is involved in social and health education programs throughout the world. Many health care professionals, medical societies, health authorities and patient groups enjoy the support of Organon.

Our ambition
Organon aims to continue being a leading and innovative company in the field of gynaecology, to build a strong position in psychiatry, consolidate our strong position within anaesthesiology and to continue research and development in these and other areas in which we have expertise and strength. We aim to be the first choice of our customers and to be a respected member of society.

Organon in the UK
Organon’s areas of interest in the UK are in contraception, menopause therapy, antidepressants, anti-psychotics, fertility treatment, anaesthesia, oncology and urology. We carry out research and development, marketing, sales and educational activities in this country, together with many supporting functions.

Organon is recognized as a world leader in contraception and the treatment of reproductive disorders. Today, it remains one of only three pharmaceutical companies substantially involved in research and development into new contraceptive methods.

Organon Laboratories Limited
Cambridge Science Park
Milton Road
Cambridge
CB4 0FL

Tel 01223 432700
Fax 01223 424368

 

Click here to obtain a copy of THE NAPC REVIEW